English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16714/19009 (88%)
Visitors : 5714381      Online Users : 227
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/28705


    標題: The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting
    作者: Chu, Chin-Chen
    Hsing, Chung-Hsi
    Shieh, Ja-Ping
    Chien, Chih-Chiang
    Ho, Chiu-Ming
    Wang, Jhi-Joung
    貢獻者: 休閒保健管理系
    關鍵字: Glucocorticoids
    Dexamethasone
    Emesis
    CINV
    RINV
    PONV
    日期: 2014-01
    上傳時間: 2015-05-06 21:25:51 (UTC+8)
    出版者: Elsevier Science Bv
    摘要: Glucocorticoids, used primarily as anti-allergic and anti-inflammatory drugs, are also effective, alone or combined with other antiemetics, for preventing nausea and vomiting. Dexamethasone, one of the glucocorticoids, has been suggested as a first-line drug for preventing low-level emetogenic chemotherapy- and radiotherapy-induced nausea and vomiting, and in patients with only one or two risks for postoperative nausea and vomiting (PONV). Dexamethasone combined with 5-HT3 or tachykinin NK1 antagonists is also suggested for higher-level emetogenic chemotherapy and radiotherapy and for patients at high risk for PONV. Glucocorticoids may act via the following mechanisms: (1) anti-inflammatory effect; (2) direct central action at the solitary tract nucleus, (3) interaction with the neurotransmitter serotonin, and receptor proteins tachykinin NK1 and NK2, alpha-adrenaline, etc.; (4) maintaining the normal physiological functions of organs and systems; (5) regulation of the hypothalamic-pituitary-adrenal axis; and (6) reducing pain and the concomitant use of opioids, which in turn reduces opioid-related nausea and vomiting. (C) 2013 Published by Elsevier B.V.
    關聯: European Journal of Pharmacology, v.722, pp.48-54
    Appears in Collections:[休閒保健管理系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML503View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback